Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction. Kensington Capital Acquisition Corp. IV executed its business combination with Amprius Technologies, Inc., a […]
Kensington Capital Acquisition Corp. IV’s Merger With Amprius Technologies
Brook + Whittle’s Acquisition of Cenveo Custom Labels Group
Hughes Hubbard & Reed represented Cenveo in the transaction while O’Melveny represented Brook + Whittle. Brook + Whittle, a leading provider of pressure sensitive and shrink […]
Cantor Fitzgerald SPAC’s $850 Million Merger With Satellogic
Hughes Hubbard and Ferrere represented CF Acquisition Corp. V in the transaction. Greenberg Traurig, Friedman, Kaplan, Seiler & Adelman and Maples and Calder advised Nettar Group, […]
Bowlero’s Merger With Isos Acquisition Corporation
Paul, Weiss, Rifkind, Wharton & Garrison LLP advised Bowlero. Davis Polk advised Atairos, a significant current holder of Bowlero’s equity. Proskauer acted as legal advisor to […]
Wallbox’s $1.5 Billion Merger with Kensington Capital Acquisition Corp. II
Latham & Watkins LLP and Loyens & Loeff represented Wallbox, while Cuatrecasas, Hughes Hubbard & Reed and Houthoff represented Kensington Capital Acquisition Corp. II in the […]
Tao Group Hospitality’s Combination With Hakkasan Group
Hughes Hubbard advised Tao Group Hospitality on the deal. Tao Group Hospitality entered into an agreement to acquire majority control of Hakkasan Group, creating a premium […]
Wabtec’s $400 Million Acquisition of Nordco
Hughes Hubbard & Reed LLP represented Greenbriar Equity Group and Nordco in the transaction. Wabtec signed an agreement to purchase Nordco for $400 million in cash, financed […]
Spireon’s Acquisition of CalAmp’s LoJack U.S. Stolen Vehicle Recovery Business
Hughes Hubbard & Reed LLP represented Spireon in the transaction. CalAmp (Nasdaq: CAMP) and Spireon executed the acquisition of the LoJack® U.S. Stolen Vehicle Recovery (SVR) business from CalAmp. The integration […]
ANI Pharmaceuticals’ Acquisiiton of Novitium Pharma
Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million […]